Potential underreporting of intravenous phenytoin adverse events [1]

Annals of Pharmacotherapy

Volumn 33, Issue 1, 1999, Pages 111-112

  Collins, M ^a   Gidal, B E ^a   Garnett, W R ^a   Reinfeldt, G ^a   Tusch, G M ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; FOSPHENYTOIN SODIUM; PHENYTOIN;

DRUG COST; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEGAL LIABILITY; LETTER; MEDICAL DOCUMENTATION; PARENTERAL DRUG ADMINISTRATION; PHLEBITIS; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN DISCOLORATION;

EID: 0032934042     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18113     Document Type: Letter

References (15)